Barclays (BCS) CEO Jes Staley is being probed by the U.K.'s financial watchdogs over an internal investigation into whistleblowing.
Shares pared earlier losses to gain 0.07% changing hands at 215.35 pence, shares have lost 8% over the past three months.
The Financial Conduct Authority and the Prudential Regulation Authority have started investigations into Staley as to his individual conduct and senior manager responsibilities related to the bank's whistleblowing program and an attempt to try to identify a whistleblower. Barclays board has formally reprimanded Staley and a "very significant compensation adjustment" will be made to his variable compensation award.
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Breaking down an approach to the long side of this biotech stock.
Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation.
If you have questions, please contact us here.
Email
Email sent
Thank you, your email to has been sent successfully.
